TY - JOUR
T1 - Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides
T2 - High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples
AU - Keller, Max
AU - Kuhn, Kilian K
AU - Einsiedel, Jürgen
AU - Hübner, Harald
AU - Biselli, Sabrina
AU - Mollereau, Catherine
AU - Wifling, David
AU - Svobodová, Jaroslava
AU - Bernhardt, Günther
AU - Cabrele, Chiara
AU - Vanderheyden, Patrick M L
AU - Gmeiner, Peter
AU - Buschauer, Armin
PY - 2016
Y1 - 2016
N2 - Derivatization of biologically active peptides by conjugation with fluorophores or radionuclide-bearing moieties is an effective and commonly used approach to prepare molecular tools and diagnostic agents. Whereas lysine, cysteine, and N-terminal amino acids have been mostly used for peptide conjugation, we describe a new, widely applicable approach to peptide conjugation based on the nonclassical bioisosteric replacement of the guanidine group in arginine by a functionalized carbamoylguanidine moiety. Four arginine-containing peptide receptor ligands (angiotensin II, neurotensin(8-13), an analogue of the C-terminal pentapeptide of neuropeptide Y, and a neuropeptide FF analogue) were subject of this proof-of-concept study. The N(ω)-carbamoylated arginines, bearing spacers with a terminal amino group, were incorporated into the peptides by standard Fmoc solid phase peptide synthesis. The synthesized chemically stable peptide derivatives showed high receptor affinities with Ki values in the low nanomolar range, even when bulky fluorophores had been attached. Two new tritiated tracers for angiotensin and neurotensin receptors are described.
AB - Derivatization of biologically active peptides by conjugation with fluorophores or radionuclide-bearing moieties is an effective and commonly used approach to prepare molecular tools and diagnostic agents. Whereas lysine, cysteine, and N-terminal amino acids have been mostly used for peptide conjugation, we describe a new, widely applicable approach to peptide conjugation based on the nonclassical bioisosteric replacement of the guanidine group in arginine by a functionalized carbamoylguanidine moiety. Four arginine-containing peptide receptor ligands (angiotensin II, neurotensin(8-13), an analogue of the C-terminal pentapeptide of neuropeptide Y, and a neuropeptide FF analogue) were subject of this proof-of-concept study. The N(ω)-carbamoylated arginines, bearing spacers with a terminal amino group, were incorporated into the peptides by standard Fmoc solid phase peptide synthesis. The synthesized chemically stable peptide derivatives showed high receptor affinities with Ki values in the low nanomolar range, even when bulky fluorophores had been attached. Two new tritiated tracers for angiotensin and neurotensin receptors are described.
KW - Angiotensin II
KW - Arginine
KW - Cells, Cultured
KW - Dose-Response Relationship, Drug
KW - Humans
KW - Ligands
KW - Molecular Structure
KW - Neuropeptide Y
KW - Neurotensin
KW - Oligopeptides
KW - Peptide Fragments
KW - Receptors, Angiotensin
KW - Receptors, Neuropeptide
KW - Receptors, Neurotensin
KW - Structure-Activity Relationship
KW - Research Support, Non-U.S. Gov't
U2 - 10.1021/acs.jmedchem.5b01495
DO - 10.1021/acs.jmedchem.5b01495
M3 - Article
C2 - 26824643
SN - 0022-2623
VL - 59
SP - 1925
EP - 1945
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 5
ER -